Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with psoriasis that significantly affects the genital area (with a severity score of 3 or higher on a standard medical scale).
- Your doctor has decided you need a biologic treatment (a type of medication given by injection), and the specific medication called tildrakizumab has been chosen as your treatment.
- You are between 18 and 99 years old.
- You are willing to sign a consent form agreeing to take part in the study.
- You have plaque psoriasis affecting at least 1% of your body surface area in an area other than the genitals.
- You are willing and able to complete questionnaires as part of the study.
Who may not be able to join:
- You are unwilling or unable to follow the study requirements, or your doctor does not think you should participate.
- You have taken part in any experimental treatment in the past 3 months before the start of the study.
- You have any health condition that means you cannot safely take tildrakizumab, including a known allergy or bad reaction to it in the past (confirm with trial site).
- You are an employee of, or otherwise dependent on, the team running the study.
- You have previously been treated with tildrakizumab.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +43 0 15953960
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Participants Achieving a Static Physician's Global Assessment of Genitalia (sPGA-G) Score of "Clear" (0) or "Almost Clear" (1); Change From Baseline in Modified Genital Psoriasis Area and Severity Index (mGPASI) Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.